期刊文献+

基质金属蛋白酶9基因-1562位点C>T多态性与冠心病关系的Meta分析 被引量:3

Association of-1562C>T polymorphism of matrix metalloproteinase-9 gene and coronary artery disease:a meta-analysis
下载PDF
导出
摘要 目的:评价基质金属蛋白酶-9基因-1562位点C〉T多态性与冠心病的关系。方法:通过PubMed,Elsevier,EMbase,CNKI等数据库搜索2012年11月30日以前发表的基质金属蛋白酶-9基因一1562位点C〉T多态性与冠心病关联性的病例对照研究文章,剔除不符合要求的文献,并根据各入选文献结果的同质性检验结果进行数据合并,计算总OR值,Meta分析采用Revman5.0及Stata11.0统计软件。结果:共有13篇病例对照研究纳入。Meta分析1Tr+CT基因型比CC基因型OR=1.29(95%CI为1.13~1.47,P〈0.01);T等位基因比c等位基因OR=1.27(95%CI为1.13-1.42,P〈0.01);CT基因型比CC+TT基因型OR=1.29(95%CI:1.13~1.48),P〈0.01)。结论:基质金属蛋白酶-9基因1562位点C〉T多态性与冠心病发病相关,基质金属蛋白酶-9基因1562位点T等位基因是冠心病易感性的标记基因。 AIM : To evaluate the relationship of matrix metalloproteinase-9 gene -1562 C 〉 T polymorphisms with coronary artery disease (CAD). METHODS: A literature search was conducted in PubMed, Elsevier, EMbase, and CNKI database to identify eligible case-control studies published before November 30, 2012 on the relationship between matrix metalloproteinase-9 gene -1562 C 〉 T polymorphism and CAD. The odds ratios of all the studies were combined, dependent on the results of heterogeneity tests among the individual studies. Review Manager ( v. 5.0) and Stata ( v. 11.0) were used for meta-analysis. RESULTS: A total of 13 case-control studies were identified. No publication bias was identified in the 13 reviewed studies. The summarized odds ratios of TT and CT genotype combination vs. CC genotype across all 13 studies was OR = 1.29 (95% , CI 1.13 - 1.47, P 〈0.01 ) , T genotype vs. C genotype was OR = 1.27 (95% , CI 1.13 - 1.42, P 〈0.01 ) , and CT genotype vs. CC and TY genotype combination was OR = 1.29 (95% , CI 1.13 - 1.48, P 〈 0. 01 ). CONCLUSION : C 〉 T polymorphism of the matrix metalloproteinase-9 gene -1562 is associated with CAD. T allele of matrix metalloproteinase-9 gene may be the susceptibility marker for CAD.
出处 《心脏杂志》 CAS 2013年第5期531-535,共5页 Chinese Heart Journal
关键词 冠状动脉疾病 基质金属蛋白酶 基因多态性 META分析 coronary artery disease matrix metalloproteinase polymorphism meta-analysis
  • 相关文献

参考文献6

二级参考文献67

  • 1张涛,郝玉明.基质金属蛋白酶与冠心病[J].临床内科杂志,2005,22(1):13-15. 被引量:16
  • 2陈晓锋,唐礼江,朱敏,江建军,沈卫峰,杜于茜.心肌梗死患者基质金属蛋白酶9基因C1562T多态性[J].中国动脉硬化杂志,2005,13(6):775-778. 被引量:9
  • 3国际心脏病学会和协会及世界卫生组织临床命名标准化联合专题组.缺血性心脏病的命名及诊断标准[J].中华心血管病杂志,1981,9(2):75-75.
  • 4[2]Burzotta F,Leone AM,Paciaroni K,Mazzari MA,Savino M,Schiavoni G,et al.G20210A prothrombin gene variant and clinical outcome in patients with a first acute coronary syndrome[J].Haematologica,2004,89 (6):1 134-138.
  • 5[5]Sundstrom J,Evans JC,Benjamin EJ,Levy D,Larson MG,Sawyer DB,et al.Relations of plasma matrix metalloproteinase-9 to clinical cardiovascular risk factors and echocardiographic left ventricular measures:the Framingham heart study[J].Circulation,2004,109 (23):2 850-856.
  • 6[6]Blankenberg S,Rupprecht HJ,Poirier O,Bickel C,Smieja M,Harfner G,et al.Plasma concentrations and genetic variation of matrix metalloproteinase-9 and prognosis of patients with cardiovascular disease[J].Circulation,2003,107 (12):1 579-585.
  • 7[7]Morgan AR,Zhang B,Tapper W,Collins A,Ye S.Haplotypic analysis of the MMP-9 gene in relation to coronary artery disease[J].J Mol Med,2003,81 (5):321-326.
  • 8[8]Fiotti N,Altamura N,Fisicaro M,Carraron N,Uxa L,Grassi G,et al.MMP-9 microsatellite polymorphism and susceptibility to carotid arteries atherosclerosis[J].Arterioscler Thromb Vasc Biol,2006,26 (6):1 330-336.
  • 9YE S, HUMPHRIES S, HENNEY A. Matrix metalloproteinases: implication in vascular matrix remodelling during atherogenesis [J]. Clin Sci, 1998, 94(2):103-110.
  • 10ZHANG B, YE S, HERRMANN SM, et al. Functional polymorphism in the regulatory region of gelatinase B gene in relation to severity of coronary atherosclerosis [J]. Circulation, 1999, 99(14) :1788-1794.

共引文献37

同被引文献46

  • 1高霞,马依彤.核因子-κB与冠心病的研究进展[J].心血管病学进展,2009,30(6):1012-1015. 被引量:6
  • 2Profumo E, Buttari B, Saso L, et al. T lymphocyte autoreactivity in inflam- matory mechanisms regulating athemsclemsis [ J ]. Scientific World Journal, 2012, 2012:157534.
  • 3Sun H, Gong S, Carrnody R J, et al. TIPE2, a negative regulator of innate and adaptive immunity that maintains immune homeostasis [J]. Cell, 2008, 133(3) :415 -426.
  • 4Freundt EC, Bidere N, Lenardo MJ, et al. A different TIPE of immune home- ostasis[J]. Cell, 2008, 133(3) :401 -402.
  • 5Zhang X, Wang J, Fan C, et al. Crystal structure of TIPE2 provides insights into immune homeostasis[J]. Nat Struct & Mol Bio, 2009, 16(10) :89 -90.
  • 6Li D, Song L, Fan Y, et al. Down-regulation of TIPE2 mRNA expression in peripheral blood mononuclear cells from patients with systemic lupuserythematosus [ J]. Clinical Immunology, 2009, 133 ( 3 ) :422 - 427.
  • 7Zhang G, Zhang W, Lou Y, et al. TIPE2 deficiency accelerates neointima formation by down regulating smooth muscle cell differenti- ation[J]. Cell Cycle, 2013, 12(3):1 -10.
  • 8Hodgkinson CP, Ye S. Toll-like reeptors, their ligands, and athero- sclerosis [ J ]. Scientific World Journal, 2011, 14 ( 11 ) :437 - 453.
  • 9Cilbert J, Lekstrom-Himes J, Donaldson D, et al. Effect of CC che- mokine receptor 2 (CCR2) blockade on serum C-reactive protein in individuals at atheroscler- otic risk and with a single nucleotide poly- morphism of the monocyte chemoattractant protein-1 promoter region [J]. Am J Cardiol, 2011, 107(6) :906 -911.
  • 10Trejakovs P, Jurka A, Bormane I, et al. Criculating ashesion mole- cules, matric metalloproteinase-9, plasminogen activator inhibitor-1, and mmyeloperoxidase in coronary artery disease patients with stable and unstable angina[ J]. Clin Chim Acta, 2012, 413 ( 1 ) ,25 - 29.

引证文献3

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部